Related Experiment Video
Updated: Jun 19, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Giant cell arteritis as a cardiovascular entity
P Houthuizen1, P E Polak, M A L Edelbroek
1Department of Cardiology, Catharina Hospital, Eindhoven, the Netherlands.
Insights
Giant cell arteritis (GCA) is an underdiagnosed condition that can lead to fatal aortic aneurysms. Early diagnosis with FDG-PET imaging and prompt glucocorticosteroid treatment can prevent severe vascular complications.
Area of Science:
- Cardiology
- Rheumatology
- Nuclear Medicine
Background:
- Giant cell arteritis (GCA) is an infrequent vasculitis.
- It is often underdiagnosed and overlooked in general cardiology.
- GCA poses a significant risk for fatal aortic aneurysms.
Purpose of the Study:
- To highlight the importance of recognizing GCA in cardiology.
- To emphasize the diagnostic role of FDG-PET imaging.
- To underscore the benefits of early GCA treatment.
Main Methods:
- Clinical history and examination.
- Laboratory investigations.
- (18)F-2-deoxy-glucose positron emission tomographic (FDG-PET) imaging for diagnosis confirmation.
Main Results:
- FDG-PET imaging can confirm suspected GCA.
- Early GCA recognition and treatment are crucial.
- Prompt glucocorticosteroid therapy reduces large-vessel complication risks.
Conclusions:
- Familiarity with GCA's clinical presentation is vital for cardiologists.
- FDG-PET imaging is a key diagnostic tool for GCA.
- Timely intervention with glucocorticosteroids mitigates severe outcomes in GCA.
Abstract:
Giant cell arteritis (GCA) is a relatively infrequent disorder that is underdiagnosed and little appraised in the field of general cardiology. However, it is important to be familiar with the clinical picture of this disease, especially because of the risk of developing fatal aortic aneurysms. If the disease is suspected after a thorough history and clinical examination combined with laboratory investigation, the diagnosis can be confirmed with (18)F-2-deoxy-glucose positron emission tomographic (FDG-PET) imaging. Early recognition of giant cell arteritis followed by prompt treatment with glucocorticosteroids will decrease the risk of developing large-vessel complications. (Neth Heart J 2009;17:281-3.).
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Myocarditis I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease I: Introduction

